Neuro-Ischemic Ulcer Type to Lead Australia & South Korea Diabetic Foot Ulcer Market During 2022–2030
According to our new research study on “Australia & South Korea Diabetic Foot Ulcer Market Size and Forecasts (2020 - 2030), Country Share, Trends, and Growth Opportunity Analysis – by Ulcer Type, Treatment Type, Infection Severity, and End User,” the Australia & South Korea diabetic foot ulcer market size was valued at US$ 199.59 billion in 2022 and is projected to reach US$ 313.53 billion by 2030; it is estimated to register a CAGR of 5.8% from 2022 to 2030. The increasing prevalence of diabetes and related chronic wounds, and a rise in the geriatric population are among the key factors driving the Australia & South Korea diabetic foot ulcer market growth.
The Australia & South Korea diabetic foot ulcer market, based on ulcer type, is segmented into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers. The neuro-ischemic ulcers segment held the largest share of the Australia & South Korea diabetic foot ulcer market in 2022, and the segment is anticipated to register the highest CAGR during 2022-2030. Diabetic patients are vulnerable to wounds, and the healing process is usually longer. Neuro-ischemia predominately leads to the development of ulcers on the foot, toes, and dorsum margins, especially on pressure sites occurring among people using poorly fitting shoes. The management of such types of wounds is comparatively complex. The wound requires prompt care, appropriate footwear, offloading, dressings, and infection treatment. However, neuro-ischemic ulcers are the most common diabetic foot ulcers (DFU). These ulcers are caused in patients with peripheral neuropathy and ischemia, resulting in peripheral artery disease. The treatment of neuro-ischemic ulcers includes referral, debridement, footwear modifications, and infection treatment through vascular surgeries and suitable drugs such as antibiotics. In addition, the wound needs to be kept clean regularly, and the blood sugar levels must be within limits to avoid any possible complications.
South Korea accounted for a larger share of the Australia & South Korea diabetic foot ulcer market in 2022. The Australia & South Korea diabetic foot ulcer market growth in the country is attributed to the growing cases of diabetes mellitus and obesity among the population and the rising incidence of chronic wounds. Diabetes is a significant public health issue nationwide, and its burden is projected to increase in the future. According to a study titled Plantar Forefoot Reconstruction in Diabetic Foot Ulcers: A Comparative Study of Perforator Valves and Accidental Valves, published in the Journal of Wound Management and Research in South Korea, the number of patients suffering from diabetes mellitus foot problems rose to ~1.4% of the total population, with 0.4% of the total population appearing each year. According to the results of the National Health and Nutrition Survey 2012–2018, 1 in 7 persons over 30 years of age, i.e., 13.8% of the adult population in South Korea, has diabetes. The older the age, the higher the prevalence of diabetes. In South Korea, the prevalence of diabetes in men in their 40s and women in their 50s is over 10%. It is estimated that 15–25% of people with diabetes would develop a foot ulcer at some point, with more than half having other complications related to the infection. In extreme cases, ~20% of moderate to severe infections require a foot amputation. Therefore, the number of diabetic patients is likely to grow with the increasing geriatric population, which, in turn, will boost the DFU market in South Korea.
Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Molnlycke Health Care AB, MiMedx Group Inc, URGO MEDICAL Australia Pty Ltd, Medline Industries LP, and Organogenesis Inc. are among the leading companies operating in the Australia & South Korea diabetic foot ulcer market.
Based on treatment type, the Australia & South Korea diabetic foot ulcer market is segmented into advanced wound care dressings, biologics, and therapy devices. The market for advanced wound care dressings is subsegmented into alginate dressings, hydrofiber dressings, foam dressings, collagen dressings, film dressings, and others. The biologics segment is further split into growth factors and skin grafts. The therapy device segment is subsegmented into negative pressure wound therapy and ultrasound therapy. In terms of ulcer type, the Australia & South Korea diabetic foot ulcer market is segmented into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers. The market, based on infection severity, is categorized as moderate, mild, and severe. Based on end user, the Australia & South Korea diabetic foot ulcer market is segmented into ambulatory surgical centers, hospitals, and home care.
Email Id: firstname.lastname@example.org